Trusted Resources: Education
Scientific literature and patient education texts
MAGE Genes: Prognostic Indicators in AL Amyloidosis Patients
source: Journal of Cellular and Molecular Medicine
year: 2019
authors: Liu Y, Wen L, Ma L, Kang Y, Liu KY, Huang XJ, Ruan GR, Lu J
summary/abstract:A high frequency of MAGE-CT (cancer testis) antigens is expressed in Multiple Myeloma (MM) patients; however, in other plasma cell dyscrasias, their potential function remains unclear. We measured the expression of MAGE-CT genes (MAGE-C1/CT7, MAGE-A3, MAGE-C2/CT10) in 105 newly diagnosed amyloid light-chain (AL) amyloidosis patients between June 2013 and January 2018 at Peking University People’s Hospital using real-time quantitative polymerase chain reaction.
DOI: 10.1111/jcmm.14475
read more full text
Related Content
-
Dysphagia Unveiling Systemic Immunoglobulin Light-Chain Amyloidosis With Multiple MyelomaDysphagia is an uncommon presentation of...
-
Eli Muchtar, MDEli Muchtar is a hematologist at Mayo cl...
-
Immunoglobulin Light-Chain Amyloidosis: From Basics to New Developments in Diagnosis, Prognosis and TherapyImmunoglobulin amyloid light-chain (AL) ...
-
FDA Approves Subcutaneous Daratumumab Plus VCd for Newly Diagnosed Light-Chain AmyloidosisThe FDA has approved daratumumab and h...
-
AL Amyloidosis: From Molecular Mechanisms to Targeted TherapiesSystemic amyloidosis is caused by misfol...
-
Attralus Update on Amyloid Fibril Targeting for Removal by Spencer Guthrie – ASG Webinar – 9/9https://www.youtube.com/watch?v=vP4wvJq5...
-
Mayo Clinic Patient Symposium in Plasma Cell Disorders 2021: Patient and Family RegistrationMayo Clinic School of Continuous Profess...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.